In preterm infants receiving paracetamol for patent ductus arteriosus (PDA) treatment, does monitoring serum paracetamol concentrations correlate with reduced risk of hepatotoxicity and improved rates of ductal closure?
Jeevahan, Jevana ; Koritena, Mahmoud ; Ali, Amira ; Noureldein, Mona
Jeevahan, Jevana
Koritena, Mahmoud
Ali, Amira
Noureldein, Mona
Abstract
No abstract available
MIDER Authors
Date
2025-04-17
Type
Article
Subject
Paediatrics
Collections
Citation
Jeevahan J, Koritena M, Ali A, Noureldein M. In preterm infants receiving paracetamol for patent ductus arteriosus (PDA) treatment, does monitoring serum paracetamol concentrations correlate with reduced risk of hepatotoxicity and improved rates of ductal closure? Arch Dis Child. 2025 Apr 17;110(5):407-409. doi: 10.1136/archdischild-2024-328436.
Journal / Source Title
Archives of Disease in Childhood
DOI
10.1136/archdischild-2024-328436
PMID
40015975
Publisher
BMJ Publishing
Publisher’s URL
https://adc.bmj.com/
